309 related articles for article (PubMed ID: 2311358)
21. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
Tiller JW; Mitchell P; Burrows GD
Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
[No Abstract] [Full Text] [Related]
22. [Antidepressive agents in the treatment of masked moods].
Demling J
Fortschr Med; 1991 Sep; 109(27):540-4. PubMed ID: 1686603
[TBL] [Abstract][Full Text] [Related]
23. Combined MAOI-tricylic antidepressant treatment: a controlled trial.
White K; Razani J; Simpson G; Rebal R; Sloane RB; O'Leary J; Palmer R
Psychopharmacol Bull; 1982 Oct; 18(4):180-1. PubMed ID: 6760234
[No Abstract] [Full Text] [Related]
24. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
Goodman WK; Charney DS
J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
[TBL] [Abstract][Full Text] [Related]
25. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
26. The pharmacological management of depression.
Murphy S; Tyrer P
Int Rehabil Med; 1984; 6(2):vi-viii. PubMed ID: 6746200
[No Abstract] [Full Text] [Related]
27. The pharmacologic treatment of depression.
Potter WZ; Rudorfer MV; Manji H
N Engl J Med; 1991 Aug; 325(9):633-42. PubMed ID: 1861697
[No Abstract] [Full Text] [Related]
28. Rational antidepressant selection.
Zetin M; Hansen J
Compr Ther; 1994; 20(4):209-23. PubMed ID: 8004923
[No Abstract] [Full Text] [Related]
29. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
Hrdina PD
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
[No Abstract] [Full Text] [Related]
30. Cardiovascular effects of antidepressants.
Cassem N
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):22-9. PubMed ID: 6816788
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology of antidepressants in use in the United States.
Richelson E
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):4-13. PubMed ID: 7174631
[No Abstract] [Full Text] [Related]
32. The new generation of antidepressants.
Feighner JP
J Clin Psychiatry; 1983 May; 44(5 Pt 2):49-55. PubMed ID: 6222037
[No Abstract] [Full Text] [Related]
33. The psychopharmacologic treatment of major depression.
Stoudemire A
J Med Assoc Ga; 1988 Nov; 77(11):821-4. PubMed ID: 3142958
[No Abstract] [Full Text] [Related]
34. Adverse effects of tricyclic and non-tricyclic antidepressants.
Beaumont G
Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():55-61. PubMed ID: 3063745
[No Abstract] [Full Text] [Related]
35. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
36. [Biologic markers and prediction of response to treatment in depression].
Uytdenhoef P; Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1982; 82(3):229-42. PubMed ID: 6187184
[No Abstract] [Full Text] [Related]
37. The role of pharmacotherapy in anorexia nervosa and bulimia.
Tolstoi LG
J Am Diet Assoc; 1989 Nov; 89(11):1640-6. PubMed ID: 2572619
[TBL] [Abstract][Full Text] [Related]
38. Current antidepressants.
Hollister LE
Annu Rev Pharmacol Toxicol; 1986; 26():23-37. PubMed ID: 3521456
[No Abstract] [Full Text] [Related]
39. Antidepressants in panic disorders.
Liebowitz MR
Br J Psychiatry Suppl; 1989 Oct; (6):46-52. PubMed ID: 2695127
[TBL] [Abstract][Full Text] [Related]
40. Strategies for the drug treatment of depression.
Cooper AJ; Magnus RV
Can Med Assoc J; 1984 Feb; 130(4):383-90. PubMed ID: 6692235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
